Max-Crown-1-265×168
For more information about product availability globally, please click below.
→APAC (Asia-Pacific)
→EMEA (Europe, Middle East, Africa)
ON has exclusive distribution rights in the following countries: Czech Republic, Slovakia, Egypt, Hong Kong, Italy, Kingdom of Saudi Arabia, Kuwait, Malaysia, Singapore, Spain, Switzerland, and United Arab Emirates; ON has non-exclusive distribution rights in Austria, France, Germany, and the Netherlands.
In November 2016, Cardiovascular Systems, Inc. (CSI) announced that Medikit, Co., Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Japan.
In February 2021, Cardiovascular Systems, Inc. (CSI) announced that PT. Revass Utama Medika signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Indonesia.
Bio-Excel (Australia) Pty. Ltd.:
In March 2021, Cardiovascular Systems, Inc. (CSI) announced that Bio-Excel Co. Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Australia.
In April 2021, Cardiovascular Systems, Inc. (CSI) announced that RSK Medical Inc. signed an exclusive sales agent agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Canada.
In August 2021, Cardiovascular Systems, Inc. (CSI) announced that CardiRad Group signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Finland, Sweden, Norway and Denmark.
In September 2021, Cardiovascular Systems, Inc. (CSI) announced that ProCardia Medical Sp. z o. o. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Poland.
In August 2021, Cardiovascular Systems, Inc. (CSI) announced that Vascular Perspectives Ltd. signed an exclusive sales agent agreement to sell its coronary and peripheral Orbital Atherectomy Systems in U.K.
SISK Healthcare/Synapse Medical
In September 2021, Cardiovascular Systems, Inc. (CSI) announced that SISK Healthcare UC Trading as Synapse Medical signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Ireland.
At CSI, weare a culture of innovation.
We observe carefully, listen closely and collaborate extensively,
seeking opportunities to help interventionalists do their jobs more easily and more effectively –
all with the goal of improving patient care.
